Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury

被引：0
|
作者：
Heikrujam Nilkanta Meitei
Anupama Pandey
Reena Haobam
机构：
[1] Manipur University,Department of Biotechnology
来源：
Molecular Biology Reports | 2023年 / 50卷
关键词：
AT-DILI; Polymorphisms; Drug metabolism genes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2893 / 2900
页数：7
相关论文
共 50 条
  • [41] N-acetyltransferase Gene Variants Involved in Pediatric Idiosyncratic Drug-Induced Liver Injury
    Ales-Palmer, Maria Luisa
    Andujar-Vera, Francisco
    Iglesias-Baena, Ivan
    Munoz-de-Rueda, Paloma
    Ocete-Hita, Esther
    BIOMEDICINES, 2024, 12 (06)
  • [42] NAT2 Gene rs1041983 is Associated with Anti-Tuberculosis Drug Induced Hepatotoxicity Among Pediatric Tuberculosis in Bandung, Indonesia
    Headriawan, Achmad
    Pramono, Alvinsyah Adhityo
    Sukadi, Abdurachman
    Chairulfatah, Alex
    Maskoen, Ani Melani
    Nataprawira, Heda Melinda
    APPLICATION OF CLINICAL GENETICS, 2021, 14 : 297 - 303
  • [43] HLA-B☆5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
    Daly, Ann K.
    Donaldson, Peter T.
    Bhatnagar, Pallav
    Shen, Yufeng
    Pe'er, Itsik
    Floratos, Aris
    Daly, Mark J.
    Goldstein, David B.
    John, Sally
    Nelson, Matthew R.
    Graham, Julia
    Park, B. Kevin
    Dillon, John F.
    Bernal, William
    Cordell, Heather J.
    Pirmohamed, Munir
    Aithal, Guruprasad P.
    Day, Christopher P.
    NATURE GENETICS, 2009, 41 (07) : 816 - U71
  • [44] Genome-Wide Analysis of DNA Methylation and Antituberculosis Drug-Induced Liver Injury in the Han Chinese Population
    Huai, Cong
    Wei, Yuqi
    Li, Mo
    Zhang, Xiaoqing
    Wu, Hao
    Qiu, Xiaoyan
    Shen, Lu
    Chen, Luan
    Zhou, Wei
    Zhang, Na
    Zhu, Guanghui
    Zhang, Ying
    Zhang, Zhiruo
    He, Lin
    Qin, Shengying
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (06) : 1389 - 1397
  • [45] Association of DNA methylation, polymorphism and mRNA level of ALAS1 with antituberculosis drug-induced liver injury
    Hao, Zhuolu
    Han, Bing
    Zhou, Xinyue
    Jian, Hongkai
    He, Xiaomin
    Lu, Lihuan
    Zhang, Meiling
    Pan, Hongqiu
    Yi, Honggang
    Tang, Shaowen
    PHARMACOGENOMICS, 2024, 25 (10-11) : 451 - 460
  • [46] Model of baseline clinicopathological features predicts non-resolution of drug-induced liver injury at 6 months
    Bihari, Chhagan
    Sharma, Shvetank
    Giri, Apoorva
    Yadav, Raj Pal
    Baweja, Sukriti
    Rastogi, Archana
    Sarin, Shiv Kumar
    HEPATOLOGY INTERNATIONAL, 2025, : 633 - 646
  • [47] Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations
    Bonkovsky, Herbert L.
    Ghabril, Marwan
    Nicoletti, Paola
    Dellinger, Andrew
    Fontana, Robert J.
    Barnhart, Huiman
    Gu, Jiezhun
    Daly, Ann K.
    Aithal, Guruprasad P.
    Phillips, Elizabeth J.
    Kleiner, David E.
    LIVER INTERNATIONAL, 2024, 44 (06) : 1409 - 1421
  • [48] Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis
    Shi, Jing
    Xie, Min
    Wang, Jianmiao
    Xu, Yongjian
    Liu, Xiansheng
    PHARMACOGENOMICS, 2015, 16 (18) : 2083 - 2097
  • [49] Genomewide Association Study Confirming the Association of NAT2 with Susceptibility to Antituberculosis Drug-Induced Liver Injury in Thai Patients
    Suvichapanich, Supharat
    Wattanapokayakit, Sukanya
    Mushiroda, Taisei
    Yanai, Hideki
    Chuchottawon, Charoen
    Kantima, Tassawan
    Nedsuwan, Supalert
    Suwankesawong, Wimon
    Sonsupap, Cholticha
    Pannarunothai, Roongkarn
    Tumpattanakul, Sukanya
    Bamrungram, Warawut
    Chaiwong, Achara
    Mahasirimongkol, Surakameth
    Mameechai, Sasithorn
    Panthong, Weerapat
    Klungtes, Nantawan
    Munsoo, Amara
    Chauychana, Udomrat
    Maneerat, Molrudee
    Fukunaga, Koya
    Omae, Yosuke
    Tokunaga, Katsushi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
  • [50] Acute kidney injury, agranulocytosis, drug-induced liver injury, and posterior reversible encephalopathy syndrome caused by high-dose methotrexate-possible role of low activity ABC and SLC drug transporters
    Bielen, L.
    Kralj, I.
    Curcic, Ela
    Vodanovic, M.
    Boban, A.
    Bozina, N.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (09) : 1191 - 1192
12345